Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Perspective Therapeutics
CATX
$342M
| $2.54M | ﹤0.01% |
1,193,927
+26,499
| +2% | +$79.5K |
|
2952
NN Inc
NNBR
$291M
| $2.54M | ﹤0.01% |
1,124,490
+26,983
| +2% | +$77.5K |
|
2953
Caledonia Mining Corp
CMCL
$420M
| $2.53M | ﹤0.01% |
202,863
-56
| -0% | -$575 |
|
2954
Foghorn Therapeutics
FHTX
$360M
| $2.52M | ﹤0.01% |
690,695
+7,832
| +1% | +$35.7K |
|
|
UPB
2955
Upstream Bio Inc
UPB
$395M
| $2.51M | ﹤0.01% |
410,677
+47,408
| +13% | +$453K |
|
|
SHCO
2956
DELISTED
Soho House & Co
SHCO
| $2.51M | ﹤0.01% |
406,069
+10,865
| +3% | +$78.6K |
|
2957
Gossamer Bio
GOSS
$87M
| $2.5M | ﹤0.01% |
2,272,448
+21,987
| +1% | +$25.4K |
|
2958
Microvast
MVST
$302M
| $2.5M | ﹤0.01% |
2,133,019
+855
| +0% | +$1.49K |
|
|
ABX
2959
Abacus Global Management
ABX
$913M
| $2.48M | ﹤0.01% |
331,165
+153,938
| +87% | +$1.17M |
|
2960
CS Disco
LAW
$279M
| $2.47M | ﹤0.01% |
604,943
+7,311
| +1% | +$35.5K |
|
2961
NI Holdings
NODK
$320M
| $2.47M | ﹤0.01% |
173,473
+4,322
| +3% | +$62.9K |
|
2962
VEON
VEON
$3.95B
| $2.45M | ﹤0.01% |
56,157
+12,835
| +30% | +$571K |
|
2963
Korro Bio
KRRO
$195M
| $2.44M | ﹤0.01% |
140,221
+3,134
| +2% | +$92.9K |
|
2964
InfuSystem Holdings
INFU
$249M
| $2.44M | ﹤0.01% |
452,581
+8,105
| +2% | +$59.3K |
|
2965
Inter&Co
INTR
$2.33B
| $2.43M | ﹤0.01% |
443,202
-1,235,623
| -74% | -$6.42M |
|
2966
SkinHealth Systems
SKIN
$85.7M
| $2.42M | ﹤0.01% |
1,805,821
+18,329
| +1% | +$27.9K |
|
2967
BRC Inc
BRCC
$250M
| $2.42M | ﹤0.01% |
1,155,475
+38,880
| +3% | +$99.1K |
|
2968
Alector
ALEC
$198M
| $2.41M | ﹤0.01% |
1,962,098
+47,848
| +2% | +$77.9K |
|
2969
Gyre Therapeutics
GYRE
$744M
| $2.41M | ﹤0.01% |
312,319
+8,221
| +3% | +$90.2K |
|
2970
Star Holdings Shares of Beneficial Interest
STHO
$116M
| $2.4M | ﹤0.01% |
281,604
+15,718
| +6% | +$137K |
|
|
SEPN
2971
Septerna Inc
SEPN
$1.75B
| $2.37M | ﹤0.01% |
409,640
+29,063
| +8% | +$332K |
|
2972
Energy Transfer Partners
ET
$69.3B
| $2.37M | ﹤0.01% |
127,494
+3,664
| +3% | +$71.4K |
|
2973
Lyell Immunopharma
LYEL
$360M
| $2.37M | ﹤0.01% |
219,957
+13,094
| +6% | +$160K |
|
2974
FuelCell Energy
FCEL
$1.63B
| $2.36M | ﹤0.01% |
514,721
+49,868
| +11% | +$372K |
|
2975
eHealth
EHTH
$43.9M
| $2.36M | ﹤0.01% |
353,570
+27,598
| +8% | +$251K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.